SINOMAB BIO-B(03681): Liang Fang appointed as Executive Director of the Company.
China Antibody-B (03681) announced that Ms. Liang Fang has been appointed as the executive director of the company, effective from July 3, 2026.
SINOMAB BIO-B (03681) announced that Ms. Liang Fang has been appointed as an executive director of the company, effective from July 3, 2026.
Related Articles
Geekplus repurchased a total of 2.62 million shares in June.
DL HOLDINGS GP (01709) spent HK$1.705 million on July 3 to repurchase 1.5 million shares.
Guotai Haitong (02611) is pleased to announce that it is expected to achieve a net profit attributable to shareholders of 20.03 billion to 20.51 billion Yuan in the mid-term, representing a year-on-year increase of 27% to 30%.
Geekplus repurchased a total of 2.62 million shares in June.
DL HOLDINGS GP (01709) spent HK$1.705 million on July 3 to repurchase 1.5 million shares.
Guotai Haitong (02611) is pleased to announce that it is expected to achieve a net profit attributable to shareholders of 20.03 billion to 20.51 billion Yuan in the mid-term, representing a year-on-year increase of 27% to 30%.
RECOMMEND
